3 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 20 points (-0.2%) at 12,795 as of Monday, Nov. 12, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,283 issues advancing vs. 1,555 declining with 129 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.1%. Top gainers within the industry include Baxter International ( BAX), up 1.0%, and Smith & Nephew ( SNN), up 0.7%. On the negative front, top decliners within the industry include ResMed ( RMD), down 3.2%, St Jude Medical ( STJ), down 1.7% and Becton Dickinson ( BDX), down 0.8%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today:

3. Fresenius Medical Care Corporation ( FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care Corporation is up $0.51 (0.8%) to $67.17 on average volume Thus far, 37,976 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 72,700 shares. The stock has ranged in price between $67.04-$67.63 after having opened the day at $67.41 as compared to the previous trading day's close of $66.66.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $20.2 billion and is part of the health care sector. The company has a P/E ratio of 19.1, above the S&P 500 P/E ratio of 17.7. Shares are down 1.6% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.

2. As of noon trading, Brookdale Senior Living ( BKD) is up $0.54 (2.4%) to $22.78 on light volume Thus far, 275,942 shares of Brookdale Senior Living exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $22.27-$23.05 after having opened the day at $22.37 as compared to the previous trading day's close of $22.24.

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. The company owns, leases, and operates retirement centers, assisted living and dementia-care communities, and continuing care retirement communities (CCRCs). Brookdale Senior Living has a market cap of $2.7 billion and is part of the health care sector. The company has a P/E ratio of -48.6, below the S&P 500 P/E ratio of 17.7. Shares are up 28.6% year to date as of the close of trading on Friday. Currently there are 6 analysts that rate Brookdale Senior Living a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Brookdale Senior Living as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and poor profit margins. Get the full Brookdale Senior Living Ratings Report now.

1. As of noon trading, DaVita HealthCare Partners ( DVA) is up $0.84 (0.8%) to $113.27 on light volume Thus far, 203,284 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 793,800 shares. The stock has ranged in price between $111.85-$113.27 after having opened the day at $112.60 as compared to the previous trading day's close of $112.43.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $10.7 billion and is part of the health care sector. The company has a P/E ratio of 20.3, above the S&P 500 P/E ratio of 17.7. Shares are up 47.5% year to date as of the close of trading on Friday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, growth in earnings per share, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full DaVita HealthCare Partners Ratings Report now.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

More from Markets

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Dow Set to Snap 8-Day Losing Streak as Stocks Recover, But Trade War Lingers

Dow Set to Snap 8-Day Losing Streak as Stocks Recover, But Trade War Lingers

OPEC, Bank Stress Tests, Disney and Tesla - 5 Things You Must Know

OPEC, Bank Stress Tests, Disney and Tesla - 5 Things You Must Know

Big Banks Pass the Stress Tests and 4 Other Stories to Watch Friday Morning

Big Banks Pass the Stress Tests and 4 Other Stories to Watch Friday Morning

OPEC Debating 1 Million Barrel Oil Market Boost as Iran Signals Support

OPEC Debating 1 Million Barrel Oil Market Boost as Iran Signals Support